Skip to main content

MODELOS MATEMATICOS EN ONCOLOGIA

PID2019-110895RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE CASTILLA-LA MANCHA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Growth exponents reflect evolutionary processes and treatment response in brain metastases.

  • Ocaña-Tienda, Beatriz
  • Pérez-Beteta, Julián
  • Jiménez-Sánchez, Juan
  • Molina-García, David
  • Ortiz de Mendivil, Ana
  • Asenjo, Beatriz
  • Albillo, David
  • Pérez-Romasanta, Luis A
  • Valiente, Manuel
  • Zhu, Lucía
  • García-Gómez, Pedro
  • González-Del Portillo, Elisabet
  • Llorente, Manuel
  • Carballo, Natalia
  • Arana, Estanislao
  • Pérez-García, Víctor M
Tumor growth is the result of the interplay of complex biological processes in huge numbers of individual cells living in changing environments. Effective simple mathematical laws have been shown to describe tumor growth in vitro, or simple animal models with bounded-growth dynamics accurately. However, results for the growth of human cancers in patients are scarce. Our study mined a large dataset of 1133 brain metastases (BMs) with longitudinal imaging follow-up to find growth laws for untreated BMs and recurrent treated BMs. Untreated BMs showed high growth exponents, most likely related to the underlying evolutionary dynamics, with experimental tumors in mice resembling accurately the disease. Recurrent BMs growth exponents were smaller, most probably due to a reduction in tumor heterogeneity after treatment, which may limit the tumor evolutionary capabilities. In silico simulations using a stochastic discrete mesoscopic model with basic evolutionary dynamics led to results in line with the observed data.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Overcoming chemotherapy resistance in low-grade gliomas: A computational approach

  • Delobel, Thibault
  • Ayala-Hernández, Luis E.
  • Bosque, Jesús J.
  • Pérez-Beteta, Julián
  • Chulian García, Salvador
  • García-Ferrer, Manuel
  • Piñero, Pilar
  • Schucht, Philippe
  • Murek, Michael
  • Pérez-García, Víctor M.
Low-grade gliomas are primary brain tumors that arise from glial cells and are usually treated with temozolomide (TMZ) as a chemotherapeutic option. They are often incurable, but patients have a prolonged survival. One of the shortcomings of the treatment is that patients eventually develop drug resistance. Recent findings show that persisters, cells that enter a dormancy state to resist treatment, play an important role in the development of resistance to TMZ. In this study we constructed a mathematical model of low-grade glioma response to TMZ incorporating a persister population. The model was able to describe the volumetric longitudinal dynamics, observed in routine FLAIR 3D sequences, of low-grade glioma patients acquiring TMZ resistance. We used the model to explore different TMZ administration protocols, first on virtual clones of real patients and afterwards on virtual patients preserving the relationships between parameters of real patients. In silico clinical trials showed that resistance development was deferred by protocols in which individual doses are administered after rest periods, rather than the 28-days cycle standard protocol. This led to median survival gains in virtual patients of more than 15 months when using resting periods between two and three weeks and agreed with recent experimental observations in animal models. Additionally, we tested adaptive variations of these new protocols, what showed a potential reduction in toxicity, but no survival gain. Our computational results highlight the need of further clinical trials that could obtain better results from treatment with TMZ in low grade gliomas.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

High-Dimensional Analysis of Single-Cell Flow Cytometry Data Predicts Relapse in Childhood Acute Lymphoblastic Leukaemia

  • Chulián, Salvador
  • Martínez Rubio, Álvaro
  • Pérez-García, Víctor M.
  • Rosa Durán, María
  • Blázquez Goñi, Cristina
  • Rodríguez Gutiérrez, Juan Francisco
  • Hermosín-Ramos, Lourdes
  • Molinos Quintana, Águeda
  • Caballero-Velázquez, Teresa
  • Ramírez-Orellana, Manuel
  • Castillo Robleda, Ana
  • Fernández-Martínez, Juan Luis
B-cell Acute Lymphoblastic Leukaemia is one of the most common cancers in childhood, with 20% of patients eventually relapsing. Flow cytometry is routinely used for diagnosis and follow-up, but it currently does not provide prognostic value at diagnosis. The volume and the high-dimensional character of this data makes it ideal for its exploitation by means of Artificial Intelligence methods. We collected flow cytometry data from 56 patients from two hospitals. We analysed differences in intensity of marker expression in order to predict relapse at the moment of diagnosis. We finally correlated this data with biomolecular information, constructing a classifier based on CD38 expression. Artificial intelligence methods may help in unveiling information that is hidden in high-dimensional oncological data. Flow cytometry studies of haematological malignancies provide quantitative data with the potential to be used for the construction of response biomarkers. Many computational methods from the bioinformatics toolbox can be applied to these data, but they have not been exploited in their full potential in leukaemias, specifically for the case of childhood B-cell Acute Lymphoblastic Leukaemia. In this paper, we analysed flow cytometry data that were obtained at diagnosis from 56 paediatric B-cell Acute Lymphoblastic Leukaemia patients from two local institutions. Our aim was to assess the prognostic potential of immunophenotypical marker expression intensity. We constructed classifiers that are based on the Fisher's Ratio to quantify differences between patients with relapsing and non-relapsing disease. We also correlated this with genetic information. The main result that arises from the data was the association between subexpression of marker CD38 and the probability of relapse.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

A Mathematical Description of the Bone Marrow Dynamics during CAR T-Cell Therapy in B-Cell Childhood Acute Lymphoblastic Leukemia

  • Martínez Rubio, Álvaro
  • Chulián, Salvador
  • Blázquez Goñi, Cristina
  • Ramírez-Orellana, Manuel
  • Pérez Martínez, Antonio
  • Navarro Zapata, Alfonso
  • Ferreras, Cristina
  • Pérez-García, Víctor M.
  • Rosa Durán, María
Chimeric Antigen Receptor (CAR) T-cell therapy has demonstrated high rates of response in recurrent B-cell Acute Lymphoblastic Leukemia in children and young adults. Despite this success, a fraction of patients' experience relapse after treatment. Relapse is often preceded by recovery of healthy B cells, which suggests loss or dysfunction of CAR T-cells in bone marrow. This site is harder to access, and thus is not monitored as frequently as peripheral blood. Understanding the interplay between B cells, leukemic cells, and CAR T-cells in bone marrow is paramount in ascertaining the causes of lack of response. In this paper, we put forward a mathematical model representing the interaction between constantly renewing B cells, CAR T-cells, and leukemic cells in the bone marrow. Our model accounts for the maturation dynamics of B cells and incorporates effector and memory CAR T-cells. The model provides a plausible description of the dynamics of the various cellular compartments in bone marrow after CAR T infusion. After exploration of the parameter space, we found that the dynamics of CAR T product and disease were independent of the dose injected, initial B-cell load, and leukemia burden. We also show theoretically the importance of CAR T product attributes in determining therapy outcome, and have studied a variety of possible response scenarios, including second dosage schemes. We conclude by setting out ideas for the refinement of the model., This work was partially supported by the Fundacion Espanola para la Ciencia y la Tecnologia (UCA PR214), the Asociacion Pablo Ugarte (APU, Spain), Junta de Comunidades de Castilla-La Mancha (SBPLY/17/180501/000154), Ministry of Science and Technology, Spain (PID2019110895RB-I00), and Inversion Territorial Integrada de la Provincia de Cadiz (ITI-0038-2019).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

In vitro biomimetic models for glioblastoma-a promising tool for drug response studies

  • Stankovic, T.
  • Randelovic, T.
  • Dragoj, M.
  • Stojkovic Buric, S.
  • Fernández, L.
  • Ochoa, I.
  • Pérez-García, V.M.
  • Pešic, M.
The poor response of glioblastoma to current treatment protocols is a consequence of its intrinsic drug resistance. Resistance to chemotherapy is primarily associated with considerable cellular heterogeneity, and plasticity of glioblastoma cells, alterations in gene expression, presence of specific tumor microenvironment conditions and blood-brain barrier. In an attempt to successfully overcome chemoresistance and better understand the biological behavior of glioblastoma, numerous tri-dimensional (3D) biomimetic models were developed in the past decade. These novel advanced models are able to better recapitulate the spatial organization of glioblastoma in a real time, therefore providing more realistic and reliable evidence to the response of glioblastoma to therapy. Moreover, these models enable the fine-tuning of different tumor microenvironment conditions and facilitate studies on the effects of the tumor microenvironment on glioblastoma chemoresistance. This review outlines current knowledge on the essence of glioblastoma chemoresistance and describes the progress achieved by 3D biomimetic models. Moreover, comprehensive literature assessment regarding the influence of 3D culturing and microenvironment mimicking on glioblastoma gene expression and biological behavior is also provided. The contribution of the blood-brain barrier as well as the blood-tumor barrier to glioblastoma chemoresistance is also reviewed from the perspective of 3D biomimetic models. Finally, the role of mathematical models in predicting 3D glioblastoma behavior and drug response is elaborated. In the future, technological innovations along with mathematical simulations should create reliable 3D biomimetic systems for glioblastoma research that should facilitate the identification and possibly application in preclinical drug testing and precision medicine.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression

  • Molina, Oscar|||0000-0001-7585-4519
  • Ortega-Sabater, C.
  • Thampi, Namitha|||0000-0001-6166-583X
  • Fernández Fuentes, Narcís|||0000-0002-6421-1080
  • Guerrero Murillo, Mercedes|||0000-0002-5556-2460
  • Martínez Moreno, Alba|||0000-0001-7514-260X
  • Vinyoles, Meritxell|||0000-0003-1906-4701
  • Velasco-Hernández, Talia|||0000-0003-2183-7443
  • Bueno, Clara|||0000-0003-1442-6216
  • Trincado Alonso, Juan Luis, 1987-|||0000-0001-5363-3774
  • Granada, Isabel|||0000-0002-4275-0104
  • Campos, Diana
  • Giménez, Carles
  • Boer, Judith M.|||0000-0003-4848-7789
  • den Boer, Monique L.
  • Calvo, Gabriel F.|||0000-0002-3623-236X
  • Camós, Mireia|||0000-0003-3658-7942
  • Fuster, José Luis|||0000-0002-4881-9440
  • Velasco Puyo, Pablo|||0000-0001-7331-9483
  • Ballerini, Paola
  • Locatelli, Franco|||0000-0002-7976-3654
  • Mullighan, Charles G.|||0000-0002-1871-1850
  • Spierings, Diana C.J.|||0000-0001-8403-474X
  • Foijer, Floris|||0000-0003-0989-3127
  • Pérez-García, Víctor M.|||0000-0002-6575-495X
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
Chromosomal instability (CIN) lies at the core of cancer development leading to aneuploidy, chromosomal copy-number heterogeneity (chr-CNH) and ultimately, unfavorable clinical outcomes. Despite its ubiquity in cancer, the presence of CIN in childhood B-cell acute lymphoblastic leukemia (cB-ALL), the most frequent pediatric cancer showing high frequencies of aneuploidy, remains unknown. Here, we elucidate the presence of CIN in aneuploid cB-ALL subtypes using single-cell whole-genome sequencing of primary cB-ALL samples and by generating and functionally characterizing patient-derived xenograft models (cB-ALL-PDX). We report higher rates of CIN across aneuploid than in euploid cB-ALL that strongly correlate with intraclonal chr-CNH and overall survival in mice. This association was further supported by in silico mathematical modeling. Moreover, mass-spectrometry analyses of cB-ALL-PDX revealed a "CIN signature" enriched in mitotic-spindle regulatory pathways, which was confirmed by RNA-sequencing of a large cohort of cB-ALL samples. The link between the presence of CIN in aneuploid cB-ALL and disease progression opens new possibilities for patient stratification and offers a promising new avenue as a therapeutic target in cB-ALL treatment.